Screening of Antiurolithiatic Drugs

Introduction & screening strategy

• Definition — Antiurolithiatic (antilithiatic / anti-calculi) drug screening is the experimental in-vitro + in-vivo evaluation of a candidate's ability to prevent, dissolve or reduce urinary calculi and the associated renal crystal deposition, hyperoxaluria and renal injury — an experimental-pharmacology topic, NOT clinical management of urolithiasis.
• Disease target modelled — Supersaturated urine drives crystal nucleation → growth → aggregation → retention → calculus; ~75–80% of human stones are calcium oxalate (CaOx), the rest calcium phosphate, struvite (Mg-ammonium-phosphate), uric acid and cystine. Models reproduce the dominant CaOx pathway or, for foreign-body/infection stones, the struvite pathway.
• Why a battery — No single assay captures nucleation-, growth- and aggregation-inhibition plus hyperoxaluria-lowering and renoprotection, so a validated programme couples cheap high-throughput in-vitro crystallisation assays (mechanism-defining) with an in-vivo lithogenic model (integrates whole-animal ion handling, crystal retention and toxicity).
• Assay hierarchy — Tier 1 — in-vitro crystallisation (nucleation / growth / aggregation of CaOx in artificial urine); Tier 2 — in-vivo lithogenic models (hyperoxaluric or foreign-body challenge in rats); Tier 3 — mechanistic endpoints (renal oxidative stress, osteopontin/CD44, renal-function protection) that separate a true anti-crystallisation drug from a mere diuretic.
• Reference comparators — Cystone® (a polyherbal Ayurvedic formulation) is the near-universal positive control in the Indian literature; potassium citrate and thiazides are the mechanism-defined pharmacological standards (citrate as a physiological CaOx-crystallisation inhibitor; thiazides as hypocalciuric agents grounded in G&G Ch.29).
• Design arms — A preventive protocol dosing the test drug from day 0 tests inhibition of stone formation; a curative protocol starting drug after calculi are established (~day 15–28) tests dissolution/regression — both arms are standard.